Vanguard Portfolio Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.05B Sell
3,896,521
-14,342
-0.4% -$8.04M 0.09% 236
2026
Q1
$2.2B Buy
+3,910,863
New +$2.51B 0.11% 186

Other funds holding IDXX

Vanguard Portfolio Management's IDXX Position: Q2 2026 in Review

Vanguard Portfolio Management reduced its Idexx Laboratories (IDXX) stake by 0.37% in Q2 2026, selling an estimated $8.04M and leaving 3,896,521 shares worth $2.05B. The position accounts for 0.09% of the portfolio, ranked #236.

Vanguard Portfolio Management first reported a position in IDXX in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.2B in Q1 2026. 1,231 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Vanguard Portfolio Management held 3,896,521 shares of Idexx Laboratories worth $2.05B as of Q2 2026.
  • Vanguard Portfolio Management sold 14,342 Idexx Laboratories shares in Q2 2026, an estimated $8.04M.
  • Idexx Laboratories made up 0.09% of Vanguard Portfolio Management's portfolio in Q2 2026, its #236 holding.
  • Vanguard Portfolio Management first reported a position in Idexx Laboratories in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Portfolio Management's Idexx Laboratories position peaked at $2.2B in Q1 2026.
  • 1,231 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.